Immunic IMUX
NASDAQ IMUX
$9.30 +0.39 (+4.38%)
At close: Sep 30, 2026 · 4:00 PM EDT

Immunic (IMUX) Other financing activities (2015 - 2019)

Updated

Immunic's Other financing activities was $188,000 in Q4 2019.

Analysis

Immunic (IMUX) Other financing activities (2015 - 2019) Analysis & Trends

For FY2019, Other financing activities at Immunic came in at $270,000.

  • The Q4 2019 figure marks the highest quarterly Other financing activities since Q3 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Immunic 395.38 Mn 395.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 188,000.00
Sep 30, 2018 -25,000.00
Jun 30, 2018 -5,000.00
Mar 31, 2018 30,000.00
Sep 30, 2017 26,000.00
Jun 30, 2017 60,000.00
Sep 30, 2016 -5,000.00
Jun 30, 2016 -10,000.00
Mar 31, 2016 30,000.00
Sep 30, 2015 270,000.00
Jun 30, 2015 51,000.00
API Access

Immunic Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=IMUX&period=max&api_key=YOUR_API_KEY